Research Article
Transarterial Infusion Chemotherapy with FOLFOX Could be an Effective and Safe Treatment for Unresectable Intrahepatic Cholangiocarcinoma
Table 1
Clinical characteristics of patients.
| | | n = 29 |
| | Age (year) | 51.4 (28.0 – 67.0) | | Sex | | Male | 21 (72.4%) | | Female | 8 (27.6%) | | WBC count (×109/L) | 7.8 ± 0.5 | | NE count (×109/L) | 5.4 ± 0.5 | | Hgb (g/L) | 133.6 ± 4.0 | | PLT count (×109/L) | 258.6 ± 21.1 | | ALT (U/L) | 25.15 (7.2 – 64.2) | | ALB (g/L) | 42.3 ± 0.8 | | TBil (umol/L) | 13.0 ± 1.0 | | PT (s) | 12.1 ± 0.1 | | CRE (umol/L) | 68.7 ± 3.1 | | AFP (ng/ml) | 4.5 (1.14 – 18,596.0) | | CA19-9 (U/ml) | 58.9 (0.6 – 20,000.0) | | CEA (ng/ml) | 3.9 (1.02 – 169.8) | | HBsAg | | Negative | 10 (34.5%) | | Positive | 19 (65.5%) | | Anti-HCV | | Negative | 29 (100.0%) | | Positive | 0 (0.0%) | | HBV-DNA | | ≤1 × 103 copies | 15 (51.7%) | | >1 × 103 copies | 14 (48.3%) | | Child–Pugh score | | 5 | 28 (96.6%) | | 6 | 1 (3.4%) | | Maximum diameter of tumor (cm) | 8.4 ± 0.6 | | Tumor numbers | | Single | 12 (41.4%) | | Multiple | 17 (58.6%) | | Tumor distribution | | Unilobe | 18 (62.1%) | | Bilobe | 11 (37.9%) | | Macrovascular invasion | | Absent | 20 (69.0%) | | Present | 9 (31.0%) | | Distant metastasis | | Absent | 18 (62.1%) | | Present | 11 (37.9%) |
|
|
